Double synergic chitosan-coated poly (lactic-co-glycolic) acid nanospheres loaded with nucleic acids as an intranasally administered vaccine delivery system to control the infection of foot-and-mouth disease virus.
Antiviral Res
; 226: 105900, 2024 Jun.
Article
en En
| MEDLINE
| ID: mdl-38705200
ABSTRACT
BACKGROUND & AIMS:
The spread of foot-and-mouth disease virus (FMDV) through aerosol droplets among cloven-hoofed ungulates in close contact is a major obstacle for successful animal husbandry. Therefore, the development of suitable mucosal vaccines, especially nasal vaccines, to block the virus at the initial site of infection is crucial. PATIENTS ANDMETHODS:
Here, we constructed eukaryotic expression plasmids containing the T and B-cell epitopes (pTB) of FMDV in tandem with the molecular mucosal adjuvant Fms-like tyrosine kinase receptor 3 ligand (Flt3 ligand, FL) (pTB-FL). Then, the constructed plasmid was electrostatically attached to mannose-modified chitosan-coated poly(lactic-co-glycolic) acid (PLGA) nanospheres (MCS-PLGA-NPs) to obtain an active nasal vaccine targeting the mannose-receptor on the surface of antigen-presenting cells (APCs).RESULTS:
The MCS-PLGA-NPs loaded with pTB-FL not only induced a local mucosal immune response, but also induced a systemic immune response in mice. More importantly, the nasal vaccine afforded an 80% protection rate against a highly virulent FMDV strain (AF72) when it was subcutaneously injected into the soles of the feet of guinea pigs.CONCLUSIONS:
The nasal vaccine prepared in this study can effectively induce a cross-protective immune response against the challenge with FMDV of same serotype in animals and is promising as a potential FMDV vaccine.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Administración Intranasal
/
Vacunas Virales
/
Virus de la Fiebre Aftosa
/
Quitosano
/
Nanosferas
/
Fiebre Aftosa
/
Copolímero de Ácido Poliláctico-Ácido Poliglicólico
Límite:
Animals
Idioma:
En
Revista:
Antiviral Res
Año:
2024
Tipo del documento:
Article